The AI drug revolution is real but the hype around it isn’t

Silicon Valley’s timeline for "solving" human health is dangerously optimistic, but AI is quietly breaking pharma’s biggest ...
Yahoo Finance

Recursion’s First AI Clinical Proof Links Pipeline Progress With Valuation Gap

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Recursion Pharmaceuticals (NasdaqGS:RXRX) reports its ...
Yahoo Finance

Recursion Pharmaceuticals (RXRX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.44, moving -1.99% from the previous trading session. This change lagged the S&P 500's 0.21% loss on the day. Meanwhile, the ...
AllHipHop

50 Cent Teases “The Algorithm” While Addressing Recent Disses

50 Cent breaks his silence with an aggressive untitled track and announces The Algorithm, his upcoming project. 50 Cent just reminded everyone why he’s still got bars when it matters. After months of ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...